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a specific condition that requires tailored solutions and 
approaches. The urgent need to tackle multimorbidity 
in a more strategic, holistic, and cost-effective manner 
was evident at the 18th European Health Forum Gastein, 
a leading annual health policy event in the European 
Union (EU), held in the autumn of 2015. This Forum 
attracted policymakers, clinicians, health service manag-
ers, patients, and a broad range of other stakeholders, all 
of whom were invited to attend a session entitled “Facing 
the Challenge of Multimorbidity”, which was supported by 
an unrestricted educational grant from MSD (a subsidiary 
of Merck & Co., Inc., NJ, USA). The session included 
presentations from many of Europe’s most influential pol-
icymakers, researchers, and campaigners on the issue of 
multimorbidity, and sparked lively discussions and debate. 
This supplement to the Journal of Comorbidity sum-
marizes the presentations and discussions from this 
important meeting, and outlines many of the key chal-
lenges we are currently facing in the management of 
multimorbidity. In the first paper [9], the epidemiology, 
risk factors, and consequences of multimorbidity are 
reviewed, highlighting how relatively little we actually 
know about multimorbidity and its determinants, or the 
effectiveness or cost-effectiveness of current interven-
tions. This lack of basic knowledge will continue to 
hamper the efforts of policymakers; however, work is 
already underway to fill some of these information gaps, 
and this paper outlines how the European Commission 
and other public bodies are contributing to this effort. 
The second paper in the supplement [10] focuses on 
different models of care and how they might be applied to 
people with multimorbidity to improve outcomes. Under 
current silo-based models, patients with multimorbidity 
Multimorbidity is a major public health challenge that 
is rising up the political and health agenda at an accel-
erated rate. Although the prevalence of multimorbidity 
increases with age, more than half of the population 
with multimorbidity are under the age of 65 years [1], 
with social deprivation a key determinant of multimor-
bidity in young and middle-aged adults [2,3]. 
From an individual’s perspective, multimorbidity 
reduces life expectancy [4–6], decreases physical func-
tioning and quality of life [7], and increases the risk of 
depression and other mental health disorders [3]. From 
a healthcare provider’s perspective, multimorbidity 
is associated with increased health service use, a high 
risk of emergency and other hospital admissions, high 
rates of polypharmacy, and spiralling costs [8]. Current 
health systems, which are typically built around a sin-
gle-disease framework, are poorly adapted to cope with 
patients with multimorbidity, who typically experience 
fragmented healthcare services, leading to potentially 
inefficient and ineffective care.
It is increasingly clear that we need to change our 
perspective on multimorbidity in order to address it as 
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are forced to navigate between multiple care providers 
who may have conflicting clinical priorities and who 
may not communicate well with each other. In these 
circumstances, care coordination becomes a challenge, 
and patients can be left feeling overwhelmed and under-
supported. This paper by Albreht et al. describes new 
integrated models of care that have been developed spe-
cifically for people with multimorbidity, and discusses 
the importance of disease prevention, patient-centred 
care delivery, multidisciplinary teamwork, and shared 
decision-making within these models.
In the third paper [11], three influential economists 
and policymakers review where we are today in terms 
of developing more sustainable health systems to tackle 
multimorbidity, and what may still be required to reduce 
the burden of disease. Again, a lack of basic knowledge 
about multimorbidity is highlighted by these experts, 
but it is clear from their review that there is a pressing 
need to strengthen primary care and develop innovative 
financing and delivery systems that measure and reward 
both quality and performance. 
Finally, the issue of patient experience of care is 
explored in the fourth paper [12], which has been co-
authored by people whose lives have been touched by 
multimorbidity. From a patient perspective, it would 
seem that being knowledgeable, experiencing good care 
coordination and communication, and being involved 
in the decision-making all contribute towards a better 
experience of care. The authors highlight the impor-
tance of integrating physical health, mental health, and 
social care, of simplifying care pathways, and of improv-
ing equitable access to quality care for all. Politicians 
and health service providers are urged by these authors 
to incorporate the views of patients when developing 
future policies on multimorbidity.
As can be seen from the articles in this special issue, 
we have reached an important milestone in the man-
agement of patients with multimorbidity. We have 
recognized that major reforms are needed, and we have 
identified key areas where more work is required. We 
have broadly agreed that greater investment is needed in 
multimorbidity prevention, in patient education for self-
management, and in strengthening primary care. We 
understand that our health systems need to be reshaped 
to deliver more patient- centred, integrated care, where 
multidisciplinary teamwork is standard and the patient 
experience is a concrete measure of care quality. We 
have seen how new integrated care models have begun 
to deliver positive results for patients and healthcare 
systems, and how incentivizing providers to manage 
patients in a more holistic way may benefit patients with 
multimorbidity in the future.
The World Health Organization, the European 
Commission, governments, policymakers, and care 
providers across Europe are at last facing the challenge 
of multimorbidity, and we look forward to hearing 
further news of the many different collaborations, ini-
tiatives, programmes, and projects underway to improve 
the management of multimorbidity in Europe. We are 
proud to have been part of such a dynamic and informa-
tive event, and are confident that there will be plenty of 
interest for all involved in the care of patients with mul-
timorbidity within the pages of this supplement.
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